INTRODUCTION:

Lipid-based nanotechnology, including nanoliposomes, nanosuspensions, nanoemulsions, strong lipid nanoparticles (SLNs), and nanostructured lipid transporters (NLCs), can be utilized to typify and scatter dynamic atoms in many structures.^1-5. Strong lipid nanoparticles (SLNs) are profoundly liked because of their inborn security, proficient conveyance system, and flexibility in obliging different lipid lattices, emulsifiers, center materials, and creation strategies. In 1991, strong lipid nanoparticles (SLNs) were presented as a further developed transporter framework contrasted with conventional colloid frameworks.^6-8. Strong lipid nanoparticles (SLNs) are a trustworthy strategy for embodying and conveying liposomes, emulsions, and polymer nanoparticles since they might be effortlessly scattered and really caught. Strong lipid nanoparticles (SLNs) are colloidal transporter frameworks made out of a lipid center with a high dissolving point, which is covered with a fluid surfactant (with a convergence of 0.5-5%) to work on the solidness of scattering.^7-8

Strong lipoprotein nanoparticles (SLNs) comprise of strong lipids, surfactants/emulsifiers, and water or different solvents. The scattered stage utilizes a strong lipid that fills in as a network for the typified compounds. Fatty oils, fractional glycerides, free unsaturated fats, steroids, and waxes are instances of strong lipids. Changing over fluid lipids into strong lipids can work on the soundness of lipophilic locales and control the rate at which covered accumulates are delivered in colloidal transporter frameworks for strong lipid nanoparticles (SLN). Strong lipids have better command over micronutrient discharge in the stomach and keep up with steadiness within the sight of ecological factors like water, light, and oxygen, when contrasted with fluid lipids.^8-11.

Furthermore, the bountiful lipid framework decelerates the course of processing, considering the progressive arrival of encased compounds. During the emulsifying stage, fluid sort surfactants are used to produce oil-in-water (O/W) or water-in-oil-in-water (W/O/W) emulsions and upgrade the dependability of strong lipid nanoparticles (SLNs)^11-13.

SLN combination/creation lipid and surfactant choice effects entanglement productivity, molecule size, soundness, crystallinity, and pharmacokinetic properties like medication bioavailability, discharge time, and retention steadiness. SLN creation strategies incorporate high velocity homogenization with ultrasonication, high-pressure homogenization, vanishing, dissolvable emulsification, and supercritical liquid extraction. Select SLN creation strategies ought to match the dynamic fixing highlights for ideal application and accomplishment of goals^13-16.

Solvent lipid nanoparticles (SLNs) act as transporters for dynamic constituents, including drugs, nutrients, minerals, anti-microbials, and cancer prevention agents. The usage of strong lipid nanoparticles (SLNs) with regards to cancer prevention agent synthetic compounds has accumulated critical interest attributable to its viability in enlarging cell reinforcement movement, bioavailability, and working with directed discharge for gastrointestinal absorption¹⁷. Different techniques, lipid frameworks, and emulsifiers/surfactants have been utilized to exemplify cell reinforcement compounds into strong lipid nanoparticles (SLNs). SLNs can promptly incorporate hydrophobic cell reinforcement compounds in light of serious areas of strength for them and resistance with the lipid grid and center stuff. The proficient epitome of hydrophilic cell reinforcements requires the improvement of emulsions, incorporating both single and twofold definitions¹⁸.

Figure 1: SLN and its Structure

The Advancement of Strong Lipid Nanoparticles (SLN'S) Innovation:

In the domain of medication embodiment, lipid nanoparticle plan (LNF) has a few remarkable advantages when contrasted with elective lipid-based transporters, for example, liposomes and emulsions inside colloidal nanocarrier frameworks. These benefits include improved motor strength and a more unbending construction. Different sorts of LNFs, like SLNs and NLCs, can be created. Strong lipid nanoparticles (SLNs) upgrade the bioavailability of micronutrients or dynamic mixtures with low dissolvability by using a strong lipid segment. Strong lipid nanoparticles (SLNs) productively convey colloidal particles like emulsions, liposomes, miniature polymers, and nanoparticles. Strong lipid nanoparticles (SLNs) comprise of dynamic synthetic mixtures, strong lipids, and surfactants. Surfactants capability as a defensive boundary that isolates the peripheral particles of the lipid network.¹⁹

At surrounding temperatures, strong lipid nanoparticles (SLNs) are made out of a minimized lipid grid, surfactants, and at times strengthening co-surfactants like solvents. Strong lipid nanoparticles (SLNs) can be created by numerous techniques, like dissolvable emulsification/vanishing, cold/hot homogenization, high-pressure/high-shear the homogenization interaction and ultrasound. The blend of strong lipid nanoparticles (SLN) requires the utilization of surfactants and different parts to improve the soundness and lucidity of lipid combinations. The usefulness of SLNs can be impacted by the surrounding temperature and planning conditions. Raised temperatures can lessen the durability of dynamic mixtures in strong lipid nanoparticles (SLNs). Besides, raised temperatures during the production of strong lipid nanoparticles (SLN) and quick cooling during the hardening system might prompt the development of shaky lipid precious stones and a diminishing in the proficiency of ensnarement. ^20-22.

Fabrication Methods for SLNs:

High-Shear Homogenization:

Ultrasonication and high-shear/fast homogenization are generally utilized and clear strategies for the development of strong lipid nanoparticles (SLNs). The underlying execution of the great shear homogenization technique yielded strong lipid nanodispersions, however with particles that stayed in the miniature measured range. Albeit a speed up may somewhat affect the polydispersity record, it doesn't be guaranteed to bring about a critical modification of molecule size. By utilizing high-recurrence cavitation energy, the blend of this strategy with ultrasonication can really diminish scattering particles to nano-sized particles. High-shear homogenization enjoys benefits, for example, the capacity to combine for a huge scope, the shortfall of natural solvents, and improved dependability of the item and medication stacking. The course of high-shear homogenization, likewise alluded to as hot homogenization, is much of the time directed under raised temperatures.^23-25.

High-Pressure Homogenization:

High-pressure homogenization (HPH) is a regularly utilized strategy. This technique can be utilized for enormous scope assembling of SLNs in modern settings. This method utilizes a strain scope of 100-2000 bar and uses 40% recipe fat. There are two methodologies accessible for SLN creation in the HPH strategy: hot and cold techniques. The course of hot homogenization involves changing the temperature to a scope of 5-10^oC higher than the liquefying point of the fat. The most common way of creating a pre-emulsion includes dissolving the micronutrient parts or dynamic mixtures in liquefied lipid and in this manner diffusing them inside the fluid surfactant stage through the use of a Ultra-Turrax blender. Hoisting temperature causes a diminishing in consistency, prompting the development of more modest and more homogeneous particles. The age of nanoparticles is affected by the nature of the pre-emulsion in this technique. Temperature and strain guideline is fundamental to forestall the weakening of dynamic synthetics^26-27.

Cold homogenization includes the disintegration of micronutrient constituents or dynamic synthetics in lipids that are currently liquefying, trailed by speedy cooling utilizing dry ice or fluid nitrogen. Cold fat is exposed to ball processing to produce microparticles with a size scope of 50-100µm. These microparticles can then be scattered inside the cool surfactant stage, bringing about the arrangement of pre-suspensions. The scattering framework is laid out by homogenizing the pre-suspension in a high-pressure reactor under freezing conditions. HPH continues until the creation of nanoparticles is accomplished. The expansion of the cool homogenization process successfully mitigates the difficulties related with hot homogenization, for example, the likely debasement of dynamic mixtures because of raised temperatures.^28-29.

Solvent Evaporation:

The cycle involves scattering fat in the oil-in-water emulsion framework to deliver strong lipid nanoparticles (SLN). Water and cyclohexane, a non-polar synthetic dissolvable, can be utilized to break up lipophilic mixtures. The natural dissolvable vanishes involving a mixing component or strain diminishing treatment to get fat microparticles. Nanoparticles are framed through the precipitation of fat microparticles³⁰.

Other Methods:

A portion of the valuable creation strategies envelop supercritical liquid, twofold emulsion, and shower drying. Supercritical liquid innovation works on the development of strong lipid nanoparticles (SLN) by dispensing with the requirement for solvents, prompting quicker and more secure activities³¹.

Strong lipid nanoparticles (SLNs) can be proficiently orchestrated utilizing supercritical carbon dioxide arrangements (RESS) strategies, alongside different forward leaps in nanoparticle creation. Ideal outcomes can be accomplished by supplanting the dissolvable with carbon dioxide (99.99%) in the creation of SLNs. The twofold emulsion strategy involves the vanishing of the dissolvable utilized for the fuse of the hydrophilic constituent into strong lipid nanoparticles (SLNs). Set up the twofold emulsion in a two-step process. To lay out a uniform microemulsion framework, present an answer containing the dynamic fixing into a combination of condensed lipid and surfactant/ cosurfactant at a temperature somewhat higher than the lipid's dissolving point. To make a water-in-oil (w/o) twofold emulsion, a water-in-oil (w/o) microemulsion is joined with water, surfactant, and cosurfactant. W/o/w emulsions are usually delivered with Tween 80. The twofold emulsion procedure for strong lipid nanoparticle (SLN) readiness is portrayed in Figure 4. The joining of hydrophilic mixtures into strong lipid nanoparticles (SLNs) requires adjustment measures to moderate the gamble of parceling into the fluid stage upon dissolvable vanishing. Subject SLNs to centrifugation at a power of 12,000 g for 30 minutes at a low temperature of ±4°C^32-33.

Different Medical and Cosmetic SLNs:

Strong lipid nanoparticles (SLNs) are regularly utilized in the field of medication to expand the bioavailability of oral meds, particularly for those with confined water solvency. Primary lipid nanoparticles (SLNs) can possibly increase the delivery, span of home, lymphatic ingestion, and bioavailability of water-insoluble drugs, including lipophilic drugs^33.

Strong lipid nanoparticles (SLNs) are appropriate for both restorative and dermatological purposes since they intently look like the construction of the skin and cause no impedance or harmfulness when applied topically. SLNs are every now and again utilized in this field with the end goal of sunscreen, hostile to skin break out, and against maturing skincare. Strong lipid nanoparticles (SLNs) can safeguard delicate parts, upgrade skin hydration, infiltrate dynamic mixtures, block bright (UV) radiation, and saturate the skin³⁴.

At the point when SLNs are applied topically, they can make an occlusive layer on the outer layer of the skin. This procedure of medication organization is impacted by the size of the SLNs, which is under 400nm. Endless supply of SLNs to the skin, the water present in the planning goes through vanishing, bringing about the arrangement of a cement layer. This layer successfully limits transepidermal water misfortune and works with the medication's entrance into more profound layers. Subsequently, the thickness of corneocytes is diminished, prompting a development of the between corneocyte hole³⁵.

Conclusions and Future Exploration:

Strong lipid nanoparticles are habitually utilized for the exemplification and transportation of lipophilic dynamic synthetics. Be that as it may, they are likewise generally used for hydrophilic mixtures, regularly using twofold emulsions or emulsifiers. The adequacy of strong lipid nanoparticle (SLN) creation is dependent upon different elements, incorporating the manufacture approach, lipid network arrangement, surfactants, emulsifiers, as well as the circumstances and techniques utilized during the readiness cycle. The usage of SLN creation is favorable in enveloping numerous dynamic mixtures. The usage of strong lipid nanoparticles (SLNs) for the embodiment of dynamic mixtures, like drugs, minerals, and cell reinforcements, requires the execution of different material blends and methods to guarantee strength and ideal capture effectiveness.

CONFLICT OF INTEREST:

There are no irreconcilable situations, as per the creators.

REFERENCES:

1. Garces A, Amaral MH, Lobo JS, Silva AC. Formulations based on solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review. European Journal of Pharmaceutical Sciences. 2018; Jan 15; 112: 159-67. DOI: 10.1016/j.ejps.2017.11.023

2. Garud A, Singh D, Garud N. Solid lipid nanoparticles (SLN): method, characterization and applications. International Current Pharmaceutical Journal. 2012; Oct 3; 1(11): 384-93. DOI:10.3329/icpj.v1i11.12065

3. Ram DT, Debnath S, Babu MN, Nath TC, Thejeswi B. A review on solid lipid nanoparticles. Research Journal of Pharmacy and Technology. 2012; Nov 1; 5(11): 2. DOI: 10.5958/0974-360X

4. Sachin J, Gupta NV. Solid lipid nanoparticles–preparation, applications, characterization, uses in various cancer therapies: a review. Research Journal of Pharmacy and Technology. 2013; 6(8): 825-37. DOI: 10.5958/0974-360X

5. Sanghavi S, Polara M, Patel D, Shah R, Patel J, Patel M. Nanoparticle drug delivery to brain–A Review. Research Journal of Pharmacy and Technology. 2012; 5(1): 8-13. DOI: 10.5958/0974-360X

6. Anagha B, Shivanand H, Manoj A, Poonam P. Effect of lipids and surfactants on solid lipid nanoparticle engineering. Research Journal of Pharmacy and Technology. 2011; 4(4): 521-6. DOI: 10.5958/0974-360X

7. Mulla JA, Suresh S, Khazi IA. Formulation, characterization and in vitro evaluation of methotrexate solid lipid nanoparticles. Research Journal of Pharmacy and Technology. 2009; 2(4): 685-9. DOI: 10.5958/0974-360X

8. Chaudhari NB, Zalte AG, Gulecha VS. Formulation, optimization, characterization and in vitro-ex vivo evaluation of atorvastatin loaded solid lipid nanoparticles using quality by design approach. Research Journal of Pharmacy and Technology. 2023; Mar 1; 16(3): 1433-41. DOI: 10.52711/0974-360X.2023.00236

9. Sharma S, Ashawat MS, Solanki NS. Isotretinoin-Loaded Solid-Lipid Nanoparticles: A Sound Strategy for Skin Targeting. Research Journal of Pharmacy and Technology. 2012; 5(11): 1375-84. DOI: 10.5958/0974-360X

10. Reddy SH, Umashankar MS, Damodharan N. Formulation, Characterization and Applications on Solid Lipid Nanoparticles-A Review. Research Journal of Pharmacy and Technology. 2018; 11(12): 5691-700. DOI: 10.5958/0974-360X.2018.01031.4

11. Sujan MN, Patil AB, Gowda DV. A Review on Methods of Preparation and Characterisation of the solid Lipid Nanoparticles. Research Journal of Pharmacy and Technology. 2020; 13(7): 3433-41. DOI: 10.5958/0974-360X.2020.00610.1

12. Jangde RK, Khan T, Bhardwaj H. Development and Characterization of Nanostructured Lipid Carrier for Topical delivery of Naringenin. Research Journal of Pharmacy and Technology. 2023; May 1; 16(5): 2572-6. DOI: 10.52711/0974-360X.2023.00422

13. Üner M. Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems. Die Pharmazie-an international Journal of Pharmaceutical Sciences. 2006; May 1; 61(5): 375-86.

14. Üner M, Yener G. Importance of solid lipid nanoparticles (SLN) in various administration routes and future perspectives. International Journal of Nanomedicine. 2007; Dec 1; 2(3): 289-300.

15. H Muller R, Shegokar R, M Keck C. 20 years of lipid nanoparticles (SLN and NLC): present state of development and industrial applications. Current drug Discovery Technologies. 2011; Sep 1; 8(3): 207-27. DOI: 10.2174/157016311796799062

16. Alsaad AA, Hussien AA, Gareeb MM. Solid lipid nanoparticles (SLN) as a novel drug delivery system: A theoretical review. Syst. Rev. Pharm. 2020; May 1; 11: 259-73. DOI: 10.31838/srp.2020.5.39

17. Saez V, Souza ID, Mansur CR. Lipid nanoparticles (SLN and NLC) for delivery of vitamin E: A comprehensive review. International Journal of Cosmetic Science. 2018; Apr; 40(2): 103-16. https://doi.org/10.1111/ics.12452

18. Burg LC, Verheijen S, Bekkers RL, IntHout J, Holloway RW, Taskin S, Ferguson SE, Xue Y, Ditto A, Baiocchi G, Papadia A. The added value of SLN mapping with indocyanine green in low-and intermediate-risk endometrial cancer management: A systematic review and meta-analysis. Journal of Gynecologic Oncology. 2022 Sep;33(5). doi: 10.3802/jgo.2022.33.e66

19. Severino P, Andreani T, Macedo AS, Fangueiro JF, Santana MH, Silva AM, Souto EB. Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery. Journal of Drug Delivery. 2012;2012. DOI: 10.1155/2012/750891

20. Souto EB, Almeida AJ, Müller RH. Lipid nanoparticles (SLN®, NLC®) for cutaneous drug delivery: structure, protection and skin effects. Journal of Biomedical Nanotechnology. 2007 Dec 1; 3(4): 317-31. DOI:10.1166/jbn.2007.049

21. Patidar A, Thakur DS, Kumar P, Verma J. A review on novel lipid based nanocarriers. Int J Pharm Pharm Sci. 2010; 2(4): 30-5.

22. Sánchez-López E, Espina M, Doktorovova S, Souto EB, García ML. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye–Part I–Barriers and determining factors in ocular delivery. European Journal of Pharmaceutics and Biopharmaceutics. 2017; Jan 1; 110: 70-5. DOI: 10.1016/j.ejpb.2016.10.009

23. Parashar AK, Kakde D, Chadhar V, Devaliya R, Shrivastav V, Jain UK. A review on solid lipid nanoparticles (SLN) for controlled and targeted delivery of medicinal agents. Current Research in Pharmaceutical Sciences. 2011; Dec 31: 37-47.

24. Costa CP, Barreiro S, Moreira JN, Silva R, Almeida H, Sousa Lobo JM, Silva AC. In vitro studies on nasal formulations of nanostructured lipid carriers (NLC) and solid lipid nanoparticles (SLN). Pharmaceuticals. 2021; Jul 23; 14(8): 711. DOI: 10.3390/ph14080711

25. Souto EB, Müller RH. Cosmetic features and applications of lipid nanoparticles (SLN®, NLC®). International journal of cosmetic science. 2008; 30(3): 157-65. DOI: 10.1111/j.1468-2494.2008.00433.x

26. Souto EB, Fangueiro JF, Fernandes AR, Cano A, Sanchez-Lopez E, Garcia ML, Severino P, Paganelli MO, Chaud MV, Silva AM. Physicochemical and biopharmaceutical aspects influencing skin permeation and role of SLN and NLC for skin drug delivery. Heliyon. 2022; 8(2): e08938. DOI: 10.1016/j.heliyon.2022.e08938

27. Campos JR, Severino P, Santini A, Silva AM, Shegokar R, Souto SB, Souto EB. Solid lipid nanoparticles (SLN): prediction of toxicity, metabolism, fate and physicochemical properties. Nanopharmaceuticals. 2020; 1-5. DOI:10.1016/B978-0-12-817778-5.00001-4

28. Fonseca-Santos B, Silva PB, Rigon RB, Sato MR, Chorilli M. Formulating SLN and NLC as innovative drug delivery systems for non-invasive routes of drug administration. Current Medicinal Chemistry. 2020; 27(22): 3623-56. DOI: 10.2174/0929867326666190624155938

29. Meads C, Sutton AJ, Rosenthal AN, Małysiak S, Kowalska M, Zapalska A, Rogozińska E, Baldwin P, Ganesan R, Borowiack E, Barton P. Sentinel lymph node biopsy in vulval cancer: systematic review and meta-analysis. British Journal of Cancer. 2014; Jun; 110(12): 2837-46. DOI: 10.1038/bjc.2014.205

30. Pardeshi C, Rajput P, Belgamwar V, Tekade A, Patil G, Chaudhary K, Sonje A. Solid lipid based nanocarriers: An overview/Nanonosaci na bazi čvrstih lipida: Pregled. Acta Pharmaceutica. 2012; Dec 1; 62(4): 433-72. DOI: 10.2478/v10007-012-0040-z

31. Radomska-Soukharev A. Stability of lipid excipients in solid lipid nanoparticles. Advanced Drug Delivery Reviews. 2007; Jul 10; 59(6): 411-8. DOI: 10.1016/j.addr.2007.04.004

32. Almeida AJ, Souto E. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Advanced Drug Delivery Reviews. 2007; 59(6): 478-90. DOI: 10.1016/j.addr.2007.04.007

33. Mehnert W, Mäder K. Solid lipid nanoparticles: production, characterization and applications. Advanced Drug Delivery Reviews. 2012; 64: 83-101. DOI: 10.1016/s0169-409x(01)00105-3

34. Yadav N, Khatak S, Sara US. Solid lipid nanoparticles-a review. Int. J. Appl. Pharm. 2013; 5(2): 8-18.

35. Ganesan P, Ramalingam P, Karthivashan G, Ko YT, Choi DK. Recent developments in solid lipid nanoparticle and surface-modified solid lipid nanoparticle delivery systems for oral delivery of phyto-bioactive compounds in various chronic diseases. International Journal of Nanomedicine. 2018; Mar 15: 1569-83. DOI: 10.2147/IJN.S155593

Received on 16.10.2023 Revised on 11.07.2024

Accepted on 05.01.2025 Published on 10.04.2025

Available online from April 12, 2025

Research J. Pharmacy and Technology. 2025;18(4):1658-1662.

DOI: 10.52711/0974-360X.2025.00237

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.